{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Inotiv, Inc."},"Symbol":{"label":"Symbol","value":"NOTV"},"Address":{"label":"Address","value":"2701 KENT AVENUE, WEST LAFAYETTE, Indiana, 47906, United States"},"Phone":{"label":"Phone","value":"+1 765 463-4527"},"Industry":{"label":"Industry","value":"Biotechnology: Commercial Physical & Biological Resarch"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery and development services to the pharmaceutical, chemical, and medical device industries, and sells analytical instruments to the pharmaceutical development and contract research industries. It operates in two principal segments - Research services and Research products."},"CompanyUrl":{"label":"Company Url","value":"https://www.inotivco.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"John Gregory Beattie","title":"COO-Discovery & Safety Assessment"},{"name":"Robert W. Leasure","title":"President, Chief Executive Officer & Director"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}